Another study demonstrated that treatment with tempol, a powerful antioxidant, of DUX4-transfected myoblasts, as well as myoblasts derived from FSHD patients, efficiently reduced the level of ROS and DNA breaks. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.